| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ikaros Transcription Factor | 58 | 2024 | 232 | 6.010 |
Why?
|
| Precursor Cells, B-Lymphoid | 6 | 2023 | 99 | 2.070 |
Why?
|
| Lymphocytes | 24 | 2022 | 2604 | 1.980 |
Why?
|
| Transcription Factors | 49 | 2022 | 12116 | 1.650 |
Why?
|
| DNA-Binding Proteins | 42 | 2014 | 9586 | 1.620 |
Why?
|
| Chromatin | 13 | 2023 | 2955 | 1.530 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 8 | 2020 | 113 | 1.500 |
Why?
|
| Cell Differentiation | 45 | 2023 | 11512 | 1.450 |
Why?
|
| DNA Helicases | 8 | 2019 | 851 | 1.210 |
Why?
|
| Lymphopoiesis | 3 | 2014 | 133 | 1.040 |
Why?
|
| Hematopoietic Stem Cells | 18 | 2014 | 3394 | 1.020 |
Why?
|
| Enhancer Elements, Genetic | 10 | 2017 | 1360 | 1.000 |
Why?
|
| Cell Lineage | 15 | 2022 | 2553 | 0.920 |
Why?
|
| B-Lymphocytes | 13 | 2023 | 4745 | 0.880 |
Why?
|
| T-Lymphocytes | 27 | 2016 | 10175 | 0.870 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2021 | 651 | 0.850 |
Why?
|
| Genome | 5 | 2023 | 1737 | 0.840 |
Why?
|
| Trans-Activators | 14 | 2015 | 2851 | 0.810 |
Why?
|
| Adenosine Triphosphatases | 5 | 2008 | 835 | 0.800 |
Why?
|
| Hematopoiesis | 10 | 2023 | 2049 | 0.790 |
Why?
|
| Histone Deacetylases | 7 | 2009 | 719 | 0.720 |
Why?
|
| Gene Expression Regulation, Developmental | 12 | 2019 | 3606 | 0.680 |
Why?
|
| Gene Expression Regulation | 17 | 2024 | 11874 | 0.680 |
Why?
|
| Transcription, Genetic | 20 | 2021 | 7583 | 0.630 |
Why?
|
| Mice | 79 | 2024 | 81368 | 0.620 |
Why?
|
| Chromatin Assembly and Disassembly | 6 | 2023 | 634 | 0.620 |
Why?
|
| Transcription Factor AP-1 | 1 | 2020 | 319 | 0.610 |
Why?
|
| Gene Regulatory Networks | 4 | 2017 | 1745 | 0.600 |
Why?
|
| Keratinocytes | 3 | 2022 | 790 | 0.580 |
Why?
|
| Zinc Fingers | 12 | 2002 | 578 | 0.570 |
Why?
|
| Promoter Regions, Genetic | 15 | 2020 | 5780 | 0.560 |
Why?
|
| Repressor Proteins | 6 | 2016 | 2985 | 0.560 |
Why?
|
| Lymphocyte Activation | 15 | 2017 | 5463 | 0.550 |
Why?
|
| Animals | 95 | 2024 | 168202 | 0.540 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2017 | 2821 | 0.540 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 2013 | 790 | 0.520 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 1551 | 0.520 |
Why?
|
| Receptors, Cytokine | 1 | 2017 | 257 | 0.520 |
Why?
|
| Thymus Gland | 15 | 2022 | 1243 | 0.500 |
Why?
|
| Precursor Cells, T-Lymphoid | 2 | 2014 | 19 | 0.500 |
Why?
|
| Cell Nucleus | 7 | 2018 | 2894 | 0.480 |
Why?
|
| Immunoglobulins | 3 | 2017 | 850 | 0.480 |
Why?
|
| Receptor, Notch1 | 2 | 2022 | 496 | 0.460 |
Why?
|
| Receptors, Antigen, T-Cell | 13 | 2016 | 2546 | 0.450 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2021 | 226 | 0.440 |
Why?
|
| Epigenesis, Genetic | 5 | 2016 | 3794 | 0.440 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 154 | 0.420 |
Why?
|
| Transcriptional Activation | 4 | 2013 | 1754 | 0.400 |
Why?
|
| Actins | 1 | 2018 | 2051 | 0.370 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2024 | 3077 | 0.350 |
Why?
|
| Mice, Transgenic | 13 | 2020 | 9526 | 0.350 |
Why?
|
| Immunity, Innate | 1 | 2022 | 3045 | 0.350 |
Why?
|
| Protein Isoforms | 6 | 2014 | 1697 | 0.350 |
Why?
|
| Mice, Knockout | 23 | 2024 | 14388 | 0.350 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 2 | 2022 | 29 | 0.340 |
Why?
|
| Base Sequence | 22 | 2015 | 12420 | 0.340 |
Why?
|
| Cell Proliferation | 7 | 2021 | 10429 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 21 | 2024 | 22117 | 0.310 |
Why?
|
| Myeloid Cells | 4 | 2013 | 823 | 0.310 |
Why?
|
| Erythroid Precursor Cells | 2 | 2007 | 212 | 0.300 |
Why?
|
| Cytokines | 4 | 2017 | 7373 | 0.290 |
Why?
|
| Bone Marrow Cells | 8 | 2008 | 2409 | 0.290 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 7 | 1992 | 897 | 0.290 |
Why?
|
| Cells, Cultured | 13 | 2020 | 18937 | 0.290 |
Why?
|
| S Phase | 3 | 2004 | 421 | 0.280 |
Why?
|
| Flow Cytometry | 10 | 2015 | 5863 | 0.280 |
Why?
|
| Signal Transduction | 16 | 2023 | 23415 | 0.280 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 382 | 0.280 |
Why?
|
| Molecular Sequence Data | 21 | 2015 | 17630 | 0.270 |
Why?
|
| Hair Follicle | 2 | 2012 | 211 | 0.260 |
Why?
|
| Skin | 1 | 2020 | 4472 | 0.260 |
Why?
|
| Dendritic Cells | 5 | 2001 | 2722 | 0.260 |
Why?
|
| Homeostasis | 6 | 2020 | 3321 | 0.250 |
Why?
|
| Multipotent Stem Cells | 1 | 2007 | 200 | 0.250 |
Why?
|
| Antigen-Presenting Cells | 2 | 2009 | 963 | 0.250 |
Why?
|
| DNA Damage | 1 | 2015 | 2445 | 0.250 |
Why?
|
| SUMO-1 Protein | 1 | 2005 | 35 | 0.250 |
Why?
|
| G1 Phase | 2 | 2004 | 403 | 0.240 |
Why?
|
| Epithelial Cells | 1 | 2016 | 3672 | 0.230 |
Why?
|
| 3T3 Cells | 7 | 2002 | 1085 | 0.230 |
Why?
|
| Drosophila Proteins | 3 | 2000 | 1698 | 0.230 |
Why?
|
| Epidermis | 1 | 2007 | 526 | 0.230 |
Why?
|
| Neutrophils | 1 | 2017 | 3763 | 0.230 |
Why?
|
| Interleukin-10 | 1 | 2009 | 1171 | 0.220 |
Why?
|
| Receptors, Interleukin-7 | 2 | 2021 | 40 | 0.210 |
Why?
|
| Protein Binding | 11 | 2017 | 9345 | 0.210 |
Why?
|
| Multigene Family | 4 | 2003 | 1076 | 0.210 |
Why?
|
| Cell Cycle Proteins | 6 | 2023 | 3447 | 0.200 |
Why?
|
| Cell Cycle | 4 | 2009 | 2929 | 0.200 |
Why?
|
| Phosphoproteins | 2 | 2002 | 2445 | 0.200 |
Why?
|
| Mice, Inbred C3H | 3 | 2015 | 913 | 0.190 |
Why?
|
| Carrier Proteins | 4 | 2002 | 4937 | 0.180 |
Why?
|
| Plasma Cells | 1 | 2004 | 597 | 0.170 |
Why?
|
| Immune Tolerance | 1 | 2009 | 2298 | 0.170 |
Why?
|
| DNA Primers | 5 | 2004 | 2817 | 0.170 |
Why?
|
| Binding Sites | 8 | 2015 | 6051 | 0.170 |
Why?
|
| Corpus Striatum | 3 | 2012 | 1235 | 0.160 |
Why?
|
| Erythroid Cells | 1 | 2020 | 238 | 0.160 |
Why?
|
| Forkhead Transcription Factors | 2 | 2024 | 1614 | 0.160 |
Why?
|
| Lymphoid Tissue | 3 | 1998 | 445 | 0.160 |
Why?
|
| Monocytes | 3 | 2023 | 2565 | 0.160 |
Why?
|
| Enkephalins | 2 | 2010 | 139 | 0.150 |
Why?
|
| Stem Cells | 5 | 2010 | 3514 | 0.150 |
Why?
|
| Cell Survival | 3 | 2019 | 5780 | 0.150 |
Why?
|
| Spleen | 6 | 2001 | 2286 | 0.150 |
Why?
|
| Autoantigens | 3 | 2014 | 888 | 0.150 |
Why?
|
| Leukopoiesis | 1 | 1997 | 54 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2013 | 2747 | 0.150 |
Why?
|
| Interferon-gamma | 2 | 2024 | 3145 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 11 | 1 | 2016 | 5 | 0.140 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2009 | 285 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2011 | 4365 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 3 | 2015 | 2063 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2022 | 725 | 0.140 |
Why?
|
| Muscle, Striated | 1 | 2016 | 17 | 0.140 |
Why?
|
| Amino Acid Sequence | 13 | 2004 | 13442 | 0.140 |
Why?
|
| Autoimmunity | 1 | 2024 | 1350 | 0.130 |
Why?
|
| Mutation | 12 | 2021 | 30015 | 0.130 |
Why?
|
| Chromosomes | 1 | 1999 | 578 | 0.130 |
Why?
|
| Apoptosis | 8 | 2021 | 9476 | 0.130 |
Why?
|
| Cell Line | 12 | 2011 | 15577 | 0.130 |
Why?
|
| Nuclear Proteins | 4 | 2002 | 5789 | 0.130 |
Why?
|
| Leukemia, T-Cell | 1 | 1995 | 101 | 0.130 |
Why?
|
| Cloning, Molecular | 7 | 2002 | 4172 | 0.120 |
Why?
|
| Interleukin-2 | 3 | 2024 | 1888 | 0.120 |
Why?
|
| Sequence Deletion | 4 | 2002 | 1490 | 0.120 |
Why?
|
| Centromere | 2 | 2006 | 212 | 0.120 |
Why?
|
| Humans | 50 | 2024 | 760740 | 0.120 |
Why?
|
| Dermatitis, Atopic | 1 | 2022 | 731 | 0.120 |
Why?
|
| Vitamin D Deficiency | 1 | 2024 | 1388 | 0.120 |
Why?
|
| Cell Division | 5 | 2004 | 4457 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 2018 | 1170 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2009 | 5304 | 0.110 |
Why?
|
| RNA, Messenger | 10 | 2003 | 12759 | 0.110 |
Why?
|
| Lymphoma, T-Cell | 1 | 1995 | 304 | 0.110 |
Why?
|
| Immunoblotting | 2 | 2014 | 1646 | 0.110 |
Why?
|
| Antigens, CD34 | 2 | 2008 | 658 | 0.100 |
Why?
|
| Pneumonia | 1 | 2024 | 2143 | 0.100 |
Why?
|
| Cell Separation | 2 | 2014 | 1718 | 0.100 |
Why?
|
| Huntington Disease | 1 | 2019 | 1144 | 0.100 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2012 | 72 | 0.100 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 2 | 2002 | 20 | 0.100 |
Why?
|
| Antigens, CD | 3 | 2008 | 3998 | 0.100 |
Why?
|
| Hair Color | 1 | 2012 | 131 | 0.100 |
Why?
|
| Deoxyribonuclease I | 2 | 2011 | 224 | 0.100 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 818 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2023 | 4433 | 0.090 |
Why?
|
| Macromolecular Substances | 4 | 1999 | 1433 | 0.090 |
Why?
|
| Brain Chemistry | 1 | 2014 | 960 | 0.090 |
Why?
|
| Alcohol Oxidoreductases | 2 | 2002 | 168 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 4 | 2012 | 2639 | 0.090 |
Why?
|
| Histones | 5 | 2013 | 2577 | 0.090 |
Why?
|
| Colony-Forming Units Assay | 2 | 2001 | 351 | 0.090 |
Why?
|
| Cell Communication | 2 | 2017 | 1654 | 0.090 |
Why?
|
| Mice, Mutant Strains | 3 | 1999 | 1748 | 0.080 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1999 | 1836 | 0.080 |
Why?
|
| DNA Replication | 1 | 2017 | 1414 | 0.080 |
Why?
|
| Mutagenesis | 3 | 2002 | 1230 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1483 | 0.080 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 1639 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2467 | 0.080 |
Why?
|
| Genomic Instability | 1 | 2013 | 709 | 0.080 |
Why?
|
| DNA | 10 | 2002 | 7196 | 0.080 |
Why?
|
| Hair | 1 | 2012 | 498 | 0.080 |
Why?
|
| beta Catenin | 1 | 2013 | 1039 | 0.080 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2007 | 10 | 0.080 |
Why?
|
| Gene Expression | 5 | 2007 | 7569 | 0.070 |
Why?
|
| Models, Immunological | 2 | 2004 | 512 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 5 | 2021 | 6126 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4569 | 0.070 |
Why?
|
| Gene Silencing | 3 | 2009 | 1503 | 0.070 |
Why?
|
| Ectoderm | 1 | 2007 | 137 | 0.070 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2001 | 888 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 1827 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 1999 | 1759 | 0.070 |
Why?
|
| Receptors, Transferrin | 1 | 2008 | 291 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2012 | 1133 | 0.070 |
Why?
|
| Neurons | 3 | 2012 | 9436 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 2803 | 0.070 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2000 | 495 | 0.070 |
Why?
|
| Klebsiella | 1 | 1985 | 49 | 0.070 |
Why?
|
| Transfection | 3 | 2002 | 5765 | 0.060 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2006 | 221 | 0.060 |
Why?
|
| Th17 Cells | 1 | 2012 | 793 | 0.060 |
Why?
|
| Carbon-Nitrogen Lyases | 1 | 2005 | 8 | 0.060 |
Why?
|
| Amino Acid Motifs | 2 | 2015 | 927 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 2413 | 0.060 |
Why?
|
| Inflammation | 3 | 2024 | 10759 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 876 | 0.060 |
Why?
|
| Asthma | 1 | 2024 | 6234 | 0.060 |
Why?
|
| Models, Genetic | 2 | 2013 | 3431 | 0.060 |
Why?
|
| Epigenomics | 1 | 2010 | 942 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 750 | 0.060 |
Why?
|
| Synapses | 1 | 2014 | 1754 | 0.060 |
Why?
|
| Lymphoma | 1 | 2013 | 1899 | 0.060 |
Why?
|
| Spondylitis, Ankylosing | 1 | 1985 | 155 | 0.060 |
Why?
|
| ras Proteins | 1 | 2009 | 1054 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2022 | 8311 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2011 | 9417 | 0.060 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2024 | 123 | 0.060 |
Why?
|
| Casein Kinase II | 1 | 2004 | 122 | 0.060 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2004 | 101 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 433 | 0.050 |
Why?
|
| Leukemia | 1 | 2011 | 1520 | 0.050 |
Why?
|
| Melanoma | 1 | 2022 | 5696 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2010 | 862 | 0.050 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2004 | 150 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 3776 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2004 | 231 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1999 | 8542 | 0.050 |
Why?
|
| Sequence Alignment | 3 | 1998 | 2178 | 0.050 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2005 | 661 | 0.050 |
Why?
|
| Chimera | 1 | 2004 | 453 | 0.050 |
Why?
|
| Clone Cells | 2 | 1996 | 1657 | 0.050 |
Why?
|
| Heterochromatin | 1 | 2005 | 291 | 0.050 |
Why?
|
| Mink Cell Focus-Inducing Viruses | 1 | 2002 | 3 | 0.050 |
Why?
|
| Cell Fractionation | 2 | 2001 | 249 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 3 | 2013 | 6188 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2000 | 1626 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 335 | 0.050 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2006 | 547 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2002 | 6520 | 0.050 |
Why?
|
| Gene Deletion | 3 | 2015 | 2659 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 1991 | 1058 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2010 | 2624 | 0.050 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2001 | 93 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2021 | 544 | 0.050 |
Why?
|
| Receptors, Complement 3d | 1 | 2001 | 117 | 0.050 |
Why?
|
| Endodeoxyribonucleases | 1 | 2002 | 164 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2002 | 3730 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 1008 | 0.050 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2000 | 74 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2000 | 4512 | 0.040 |
Why?
|
| HLA Antigens | 1 | 1985 | 1327 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 1985 | 1141 | 0.040 |
Why?
|
| Face | 1 | 2006 | 1026 | 0.040 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1999 | 138 | 0.040 |
Why?
|
| Transcription Factor DP1 | 1 | 1999 | 136 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2000 | 813 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 2000 | 195 | 0.040 |
Why?
|
| Immunization | 1 | 2004 | 1217 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 4 | 2002 | 6074 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2004 | 868 | 0.040 |
Why?
|
| Tissue Transplantation | 1 | 1999 | 128 | 0.040 |
Why?
|
| Phagocytes | 1 | 2001 | 295 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2001 | 4340 | 0.040 |
Why?
|
| Blood Cells | 1 | 2001 | 305 | 0.040 |
Why?
|
| E2F Transcription Factors | 1 | 1999 | 269 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2008 | 2410 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2024 | 1056 | 0.040 |
Why?
|
| Recombination, Genetic | 3 | 2013 | 1519 | 0.040 |
Why?
|
| Animals, Newborn | 3 | 2014 | 2669 | 0.040 |
Why?
|
| Dimerization | 2 | 1998 | 890 | 0.040 |
Why?
|
| Interferons | 1 | 2022 | 702 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2000 | 565 | 0.040 |
Why?
|
| Yeasts | 1 | 1999 | 278 | 0.040 |
Why?
|
| Bone Marrow | 2 | 1999 | 2909 | 0.040 |
Why?
|
| Computational Biology | 1 | 2010 | 3509 | 0.040 |
Why?
|
| Radiation Chimera | 1 | 1997 | 215 | 0.040 |
Why?
|
| Thymoma | 2 | 1990 | 188 | 0.040 |
Why?
|
| Gene Targeting | 2 | 2005 | 837 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2004 | 1355 | 0.030 |
Why?
|
| Neprilysin | 1 | 2000 | 478 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18220 | 0.030 |
Why?
|
| Disease Progression | 1 | 2014 | 13495 | 0.030 |
Why?
|
| Egtazic Acid | 1 | 1996 | 167 | 0.030 |
Why?
|
| Sigmoidoscopes | 1 | 1996 | 5 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 1997 | 310 | 0.030 |
Why?
|
| Acetylation | 1 | 1999 | 1055 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2007 | 3688 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2021 | 2625 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2001 | 1964 | 0.030 |
Why?
|
| Sigmoid Neoplasms | 1 | 1996 | 53 | 0.030 |
Why?
|
| Gastric Outlet Obstruction | 1 | 1996 | 54 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 1999 | 727 | 0.030 |
Why?
|
| Vitamins | 1 | 2024 | 1635 | 0.030 |
Why?
|
| Blotting, Northern | 3 | 1992 | 1545 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2005 | 1894 | 0.030 |
Why?
|
| Nucleosomes | 1 | 1999 | 487 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2001 | 1250 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1996 | 310 | 0.030 |
Why?
|
| Plasmids | 1 | 2000 | 2265 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 2000 | 2802 | 0.030 |
Why?
|
| Interleukins | 1 | 2000 | 783 | 0.030 |
Why?
|
| Chelating Agents | 1 | 1996 | 387 | 0.030 |
Why?
|
| Phenotype | 4 | 2019 | 16572 | 0.030 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1996 | 164 | 0.030 |
Why?
|
| Retinoblastoma-Binding Protein 4 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Mitochondria, Heart | 1 | 2016 | 229 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1996 | 346 | 0.030 |
Why?
|
| Neoplasms | 2 | 2024 | 22131 | 0.030 |
Why?
|
| Genes, RAG-1 | 1 | 2013 | 67 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 1999 | 774 | 0.030 |
Why?
|
| Stents | 2 | 1996 | 3177 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1997 | 1162 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2014 | 381 | 0.030 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2013 | 72 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3705 | 0.030 |
Why?
|
| Models, Biological | 3 | 1999 | 9461 | 0.030 |
Why?
|
| Juvenile Hormones | 1 | 1992 | 15 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 2 | 2019 | 4408 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3599 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1995 | 851 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2013 | 174 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 1996 | 684 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2000 | 5034 | 0.030 |
Why?
|
| Melanosomes | 1 | 2012 | 33 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 2014 | 226 | 0.030 |
Why?
|
| Exons | 2 | 1996 | 2381 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 852 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 1993 | 286 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2000 | 2916 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1996 | 1989 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 1999 | 1768 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 2002 | 4611 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1997 | 1056 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2021 | 2481 | 0.030 |
Why?
|
| Activating Transcription Factor 2 | 1 | 1992 | 44 | 0.030 |
Why?
|
| Zinc | 1 | 1996 | 687 | 0.030 |
Why?
|
| Intestinal Obstruction | 1 | 1996 | 432 | 0.020 |
Why?
|
| Leucine Zippers | 1 | 1992 | 116 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2019 | 3601 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1995 | 531 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 2425 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1998 | 938 | 0.020 |
Why?
|
| Activin Receptors, Type II | 1 | 2012 | 123 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 1986 | 1606 | 0.020 |
Why?
|
| CpG Islands | 1 | 2016 | 1192 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1988 | 550 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2015 | 1525 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1996 | 898 | 0.020 |
Why?
|
| Liver | 3 | 1998 | 7512 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 370 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2012 | 262 | 0.020 |
Why?
|
| Palliative Care | 2 | 1996 | 3593 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2003 | 2152 | 0.020 |
Why?
|
| Vitamin D | 1 | 2024 | 3301 | 0.020 |
Why?
|
| Anemia | 1 | 1999 | 1504 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2012 | 220 | 0.020 |
Why?
|
| Cyclin D3 | 1 | 2009 | 54 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1998 | 2115 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2010 | 114 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1994 | 1088 | 0.020 |
Why?
|
| Efferent Pathways | 1 | 2010 | 165 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 2100 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1992 | 502 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 292 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2013 | 612 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 360 | 0.020 |
Why?
|
| Forecasting | 1 | 1998 | 2924 | 0.020 |
Why?
|
| Heterozygote | 1 | 1995 | 2780 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2009 | 265 | 0.020 |
Why?
|
| Melanocytes | 1 | 2012 | 509 | 0.020 |
Why?
|
| Substance P | 1 | 2010 | 335 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1999 | 2916 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1996 | 1797 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1992 | 2261 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 2674 | 0.020 |
Why?
|
| Lymph Nodes | 2 | 2002 | 3461 | 0.020 |
Why?
|
| Tubulin | 1 | 2012 | 692 | 0.020 |
Why?
|
| Genes | 2 | 1989 | 1823 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 29601 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2009 | 254 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 871 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2013 | 1392 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1988 | 777 | 0.020 |
Why?
|
| Alleles | 1 | 2019 | 6861 | 0.020 |
Why?
|
| Alopecia | 1 | 2012 | 412 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 2057 | 0.020 |
Why?
|
| Immunoglobulin Light Chains, Surrogate | 1 | 2007 | 5 | 0.020 |
Why?
|
| Hybridomas | 1 | 1988 | 442 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2016 | 1667 | 0.020 |
Why?
|
| Cyclins | 1 | 2009 | 594 | 0.020 |
Why?
|
| Thymus Neoplasms | 1 | 1990 | 274 | 0.020 |
Why?
|
| Rectal Neoplasms | 1 | 1996 | 1156 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 614 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 310 | 0.020 |
Why?
|
| Brain | 1 | 2013 | 27100 | 0.020 |
Why?
|
| Embryo Loss | 1 | 2006 | 55 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 1994 | 1852 | 0.020 |
Why?
|
| Chemokine CCL19 | 1 | 2005 | 35 | 0.020 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 183 | 0.020 |
Why?
|
| HLA-B27 Antigen | 1 | 1985 | 63 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 1996 | 1459 | 0.020 |
Why?
|
| Immune Sera | 1 | 1985 | 605 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 1994 | 2191 | 0.020 |
Why?
|
| Drosophila | 1 | 1992 | 1494 | 0.020 |
Why?
|
| Rats | 2 | 2014 | 23716 | 0.020 |
Why?
|
| Macrophages | 1 | 2000 | 5758 | 0.010 |
Why?
|
| Chemokines, CC | 1 | 2005 | 283 | 0.010 |
Why?
|
| Cerebellum | 1 | 2012 | 1501 | 0.010 |
Why?
|
| DNA Repair | 1 | 2013 | 2043 | 0.010 |
Why?
|
| Genotype | 1 | 2019 | 12977 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 1948 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2005 | 416 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2011 | 4570 | 0.010 |
Why?
|
| Chemokine CXCL12 | 1 | 2005 | 454 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1985 | 816 | 0.010 |
Why?
|
| Colitis | 1 | 2012 | 1234 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 1738 | 0.010 |
Why?
|
| Immune Complex Diseases | 1 | 2003 | 50 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 8165 | 0.010 |
Why?
|
| Heart | 1 | 2016 | 4403 | 0.010 |
Why?
|
| Age Factors | 1 | 1999 | 18381 | 0.010 |
Why?
|
| Mice, Inbred AKR | 1 | 2002 | 104 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 1074 | 0.010 |
Why?
|
| Serine | 1 | 2005 | 830 | 0.010 |
Why?
|
| Time Factors | 2 | 2011 | 39908 | 0.010 |
Why?
|
| Retroviridae Infections | 1 | 2002 | 147 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 2002 | 225 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 2003 | 342 | 0.010 |
Why?
|
| Male | 6 | 2015 | 360402 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 740 | 0.010 |
Why?
|
| Germinal Center | 1 | 2003 | 380 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 1670 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 3793 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2002 | 516 | 0.010 |
Why?
|
| Syndrome | 1 | 2006 | 3268 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2013 | 4392 | 0.010 |
Why?
|
| Female | 5 | 2015 | 392203 | 0.010 |
Why?
|
| Epistasis, Genetic | 1 | 2001 | 350 | 0.010 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 435 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2001 | 777 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1985 | 3798 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 1692 | 0.010 |
Why?
|
| Yolk Sac | 1 | 1998 | 79 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1996 | 5369 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1988 | 4140 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1996 | 9277 | 0.010 |
Why?
|
| Aging | 1 | 2016 | 8700 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 2456 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 2896 | 0.010 |
Why?
|
| Gastroscopy | 1 | 1996 | 211 | 0.010 |
Why?
|
| Adult | 2 | 2000 | 220995 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 1998 | 1970 | 0.010 |
Why?
|
| Metals | 1 | 1996 | 719 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1988 | 5144 | 0.010 |
Why?
|
| Calcimycin | 1 | 1989 | 213 | 0.010 |
Why?
|
| Antibodies | 1 | 1998 | 2413 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1989 | 343 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1988 | 851 | 0.000 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1988 | 287 | 0.000 |
Why?
|
| Genes, Immunoglobulin | 1 | 1988 | 285 | 0.000 |
Why?
|
| Equipment Design | 1 | 1996 | 3501 | 0.000 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1989 | 410 | 0.000 |
Why?
|
| Immunoglobulin delta-Chains | 1 | 1986 | 7 | 0.000 |
Why?
|
| Chromosome Deletion | 1 | 1991 | 1386 | 0.000 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1988 | 584 | 0.000 |
Why?
|
| Endoscopy | 1 | 1996 | 1851 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1989 | 1503 | 0.000 |
Why?
|
| Introns | 1 | 1987 | 968 | 0.000 |
Why?
|
| Radiography | 1 | 1996 | 6961 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1988 | 3074 | 0.000 |
Why?
|
| Genetic Linkage | 1 | 1987 | 2340 | 0.000 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1986 | 1349 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1996 | 11118 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1988 | 4110 | 0.000 |
Why?
|
| Epitopes | 1 | 1986 | 2501 | 0.000 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1986 | 1779 | 0.000 |
Why?
|
| Calcium | 1 | 1989 | 5717 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 39062 | 0.000 |
Why?
|
| Aged | 2 | 1996 | 169092 | 0.000 |
Why?
|
| Middle Aged | 2 | 1996 | 220603 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1996 | 58919 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1996 | 80583 | 0.000 |
Why?
|